Ovid Therapeutics, Inc. (OVID)

1.56 -0.01 (-0.64%) USD  |  NASDAQ  |  Jan 20, 11:40
More

Ovid Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
AnaptysBio, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Cassava Sciences, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade